PetMed Express Q1 2025 GAAP EPS $0.18 Beats $(0.06) Estimate, Sales $67.952M Miss $75.000M Estimate
Portfolio Pulse from Benzinga Newsdesk
PetMed Express (NASDAQ:PETS) reported Q1 2025 earnings per share (EPS) of $0.18, significantly beating the analyst consensus estimate of $(0.06). However, the company's sales of $67.952 million missed the $75.000 million estimate and represented a 13.15% decrease from the same period last year.
August 06, 2024 | 9:48 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
PetMed Express reported Q1 2025 EPS of $0.18, beating estimates by 400%, but sales of $67.952 million missed the $75.000 million estimate and were down 13.15% YoY.
The significant EPS beat is a positive indicator, but the sales miss and YoY decline in revenue are concerning. These mixed results may lead to neutral short-term price movement as investors weigh the strong earnings against the weak sales performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100